Profound Medical Corp. splits its revenue into 3 lines in its filings. The largest line in fiscal 2025, which ended Dec 31, 2025 was Recurring Non Capital at $9.7 million, 60% of the total.
USD in millions. The percent under a figure is the change from the year before.
| Line |
FY 2026
Jun 30, 2026
|
FY 2025
Dec 31, 2025
|
FY 2024
Dec 31, 2024
|
FY 2023
Dec 31, 2023
|
FY 2022
Dec 31, 2022
|
FY 2021
Dec 31, 2021
|
FY 2020
Dec 31, 2020
|
|---|---|---|---|---|---|---|---|
| Revenue |
19
|
16
|
11
|
6
|
6
|
6
|
7
|
| Recurring Non Capital |
10
+20.1%
share 54.8%
|
10
+18.1%
share 60.4%
|
8
+21.1%
share 77.2%
|
7
share 115.4%
|
—
|
—
|
—
|
| Capital Equipment |
9
+175.2%
share 45.2%
|
6
+161.0%
share 39.6%
|
2
-55.7%
share 22.8%
|
6
+38.8%
share 93.3%
|
4
+25.9%
share 66.4%
|
3
-31.2%
share 48.9%
|
5
share 62.7%
|
| Non Capital Recurring |
—
|
—
|
—
|
0
-80.4%
share 6.7%
|
2
-39.1%
share 33.6%
|
3
+36.7%
share 51.1%
|
2
share 33.0%
|
How these figures are calculated
Annual columns are full-year amounts from the annual report (Form 10-K, 20-F, or 40-F). If a company restates a year, the latest filed number is shown. USD in millions. Each group is a separate split of total revenue, so the groups are not added together. Share of revenue is that line divided by total revenue. The first column adds the latest year-to-date segment amount to the last fiscal year and subtracts the year-ago year-to-date amount. More on our methodology.
Company profile
- Industry
- Surgical & Medical Instruments & Apparatus (SIC 3841)
- Listed as
- PROF (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- Ontario, Canada
- Headquarters
- Mississauga, Ontario, Canada
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1628808
Other Surgical & Medical Instruments & Apparatus companies
- Stryker Corp SYK
- 3M Co MMM
- Boston Scientific Corp BSX
- Becton Dickinson & Co BDX
- Medline Inc. MDLN
- Resmed Inc RMD
- Dexcom Inc DXCM
- Fresenius SE & Co. KGaA FSNUY
All 151 Surgical & Medical Instruments & Apparatus companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.